Hemoglobin Balkh, a Novel Mutation in Codon 132 of α2-Globin Gene [α132(H15) (+T) or HBA2:C.396dup (p.Val134fs)]: A Case Report and Insight into the Pathophysiology
Shabnam Tavassoli Jong H. Chung Arun R. Panigrahi Azadeh Shahsavar Ashutosh Lal Sylvia Titi Singer a Hemoglobinopathy Reference Laboratory,UCSF Benioff Children's Hospital,Oakland,CA,USAb Division of Pediatric Hematology-Oncology,University of California,Los Angeles,Miller Children's Hospital,Long Beach,CA,USAc Division of Pediatric Hematology/Oncology/BMT,University of California,Davis,CA,USAd Department of Drug Design and Pharmacology,University of Copenhagen,Copenhagen,Denmarke Department of Hematology/Oncology,Hemoglobinopathy Reference Laboratory,UCSF Benioff Children's Hospital,Oakland,CA,USA
DOI: https://doi.org/10.1080/03630269.2024.2410295
2024-10-18
Hemoglobin
Abstract:We report a novel mutation on α2-globin gene leading to an elongated α-chain. This novel frameshift mutation was detected in a 13-year-old boy from Balkh province, Afghanistan. DNA analysis identified an insertion of thymine (T) at codon 132 [ HBA2 :c.396dup (p.Val134fs)]. We named the novel hemoglobin variant 'Hemoglobin Balkh' after the geographic location from which the patient originated. This novel variant was found in association with α3.7 kb α-globin gene deletion, suggesting a compound heterozygous state that contributes to the patient's clinical presentation.
biochemistry & molecular biology,hematology